外显子组测序揭示圆头精子症的新病因及新候选基因
该研究对15例不明原因的圆头精子症或顶体发育不良患者进行外显子组测序,在8例中检出可能致病变异,涉及ZPBP、CCDC62等7个新基因;其中ZPBP和CCDC62的功能已在敲除小鼠模型中得到验证,扩展了圆头精子症的遗传病因谱。
要点
- 外显子组测序在15例不明原因圆头精子症患者中检出8例可能致病变异。
- 发现ZPBP和CCDC62为新的圆头精子症致病基因,并在小鼠模型验证。
- 鉴定出C2CD6、CCIN、C7orf61、DNAH17和GGN等新候选基因。
核心结论
- 外显子组测序在15例不明原因圆头精子症患者中发现7个新基因的致病变异,其中ZPBP和CCDC62经小鼠模型验证为致病基因。
研究设计与样本
- 先对16例患者筛查已知基因DPY19L2和SPATA16,排除1例DPY19L2突变后,对15例不明原因圆头精子症或顶体发育不良患者行外显子组测序。
主要发现
- 15例接受外显子组测序的患者中,8例检出可能致病变异。
- 2例无亲缘关系患者分别携带ZPBP和CCDC62纯合无义突变。
- 另6例患者携带C2CD6、CCIN、C7orf61、DNAH17的罕见错义突变及GGN移码突变。
- 除DNAH17变异外,外显子组测序检出的所有变异均位于纯合区域。
- C7orf61突变患者精子超微结构显示圆头无顶体与卵圆形或不规则头伴小顶体的混合表型。
关键数值与推荐
- 变异筛选标准:GnomAD人群数据库中等位基因频率<0.5%的隐性及X连锁蛋白改变变异,且基因在睾丸中表达增强。
临床怎么用
- 对常规基因筛查阴性的圆头精子症患者,可考虑外显子组测序以明确遗传病因,辅助预测辅助生殖治疗结局。
局限性
- 外显子数据分析采用严格过滤标准,可能遗漏致病性变异。
- 多个候选基因尚需功能学后续验证以确认其对正常精子发生的影响。
- 部分患者家系成员DNA不可及,限制共分离分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can exome sequencing identify new genetic causes of globozoospermia? SUMMARY ANSWER: Exome sequencing in 15 cases of unexplained globozoospermia revealed deleterious mutations in seven new genes, of which two have been validated as causing globozoospermia when knocked out in mouse models. WHAT IS KNOWN ALREADY: Globozoospermia is a rare form of male infertility characterised by round-headed sperm and malformation of the acrosome. Although pathogenic variants in DPY19L2 and SPATA16 are known causes of globozoospermia and explain up to 70% of all cases, genetic causality remains unexplained in the remaining patients. STUDY DESIGN, SIZE, DURATION: After pre-screening 16 men for mutations in known globozoospermia genes DPY19L2 and SPATA16, exome sequencing was performed in 15 males with globozoospermia or acrosomal hypoplasia of unknown aetiology. PARTICIPANTS/MATERIALS, SETTING, METHOD: Targeted next-generation sequencing and Sanger sequencing was performed for all 16 patients to screen for single-nucleotide variants and copy number variations in DPY19L2 and SPATA16. After exclusion of one patient with DPY19L2 mutations, we performed exome sequencing for the 15 remaining subjects. We prioritised recessive and X-linked protein-altering variants with an allele frequency of <0.5% in the population database GnomAD in genes with an enhanced expression in the testis. All identified candidate variants were confirmed in patients and, where possible, in family members using Sanger sequencing. Ultrastructural examination of semen from one of the patients allowed for a precise phenotypic characterisation of abnormal spermatozoa. MAIN RESULTS AND ROLE OF CHANCE: After prioritisation and validation, we identified possibly causative variants in eight of 15 patients investigated by exome sequencing. The analysis revealed homozygous nonsense mutations in ZPBP and CCDC62 in two unrelated patients, as well as rare missense mutations in C2CD6 (also known as ALS2CR11), CCIN, C7orf61 and DHNA17 and a frameshift mutation in GGN in six other patients. All variants identified through exome sequencing, except for the variants in DNAH17, were located in a region of homozygosity. Familial segregation of the nonsense variant in ZPBP revealed two fertile brothers and the patient's mother to be heterozygous carriers. Paternal DNA was unavailable. Immunohistochemistry confirmed that ZPBP localises to the acrosome in human spermatozoa. Ultrastructural analysis of spermatozoa in the patient with the C7orf61 mutation revealed a mixture of round heads with no acrosomes (globozoospermia) and ovoid or irregular heads with small acrosomes frequently detached from the sperm head (acrosomal hypoplasia). LIMITATIONS, REASONS FOR CAUTION: Stringent filtering criteria were used in the exome data analysis which could result in possible pathogenic variants remaining undetected. Additionally, functional follow-up is needed for several candidate genes to confirm the impact of these mutations on normal spermatogenesis. WIDER IMPLICATIONS OF THE FINDINGS: Our study revealed an important role for mutations in ZPBP and CCDC62 in human globozoospermia as well as five new candidate genes. These findings provide a more comprehensive understanding of the genetics of male infertility and bring us closer to a complete molecular diagnosis for globozoospermia patients which would help to predict the success of reproductive treatments. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by The Netherlands Organisation for Scientific Research (918-15-667); National Health and Medical Research Council of Australia (APP1120356) and the National Council for Scientific Research (CONICET), Argentina, PIP grant 11220120100279CO. The authors have nothing to disclose.
引用
- Oud MS, Okutman Ö, Hendricks LAJ, et al. Exome sequencing reveals novel causes as well as new candidate genes for human globozoospermia. Hum Reprod. 2020. PMID: 31985809. doi:10.1093/humrep/dez246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。